Improving outcomes in rheumatoid arthritis: what determines decisions to change ineffective therapy?
Sokka, T.; Mäkinen, H.
Journal of Rheumatology 33(7): 1213-1215
2006
ISSN/ISBN: 0315-162X PMID: 16821259 Document Number: 600687
Document emailed within 1 workday
Related Documents
Soubrier, M.; Zerkak, D.; Gossec, L.; Ayral, X.; Roux, C.; Dougados, M. 2006: Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice? Journal of Rheumatology 33(7): 1243-1246Krause, D.; Gabriel, B.; Herborn, G.; Braun, J.; Rau, R. 2015: Radiologic damage at baseline predicts patient-related outcomes 18 years after the initiation of methotrexate therapy in patients with severe rheumatoid arthritis Clinical and Experimental Rheumatology 33(5): 611-616
De Filippis, L.; Caliri, A.; Anghelone, S.; Scibilia, G.; Lo Gullo, R.; Bagnato, G. 2006: Improving outcomes in tumour necrosis factor a treatment: comparison of the efficacy of the tumour necrosis factor a blocking agents etanercept and infliximab in patients with active rheumatoid arthritis Panminerva Medica 48(2): 129-135
Lee, S.J.; Lenert, L.; Weisman, S.; Kavanaugh, A. 2005: Factors affecting rheumatoid arthritis patients' decisions to participate in clinical trials Journal of Rheumatology 32(12): 2317-2325
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Sheridan, J.E.; White, J.; Fairchild, T.J. 1992: Ineffective staff, ineffective supervision, or ineffective administration? Why some nursing homes fail to provide adequate care Gerontologist 32(3): 334-341
Caplan, L.; Wolfe, F.; Russell, A.S.; Michaud, K. 2007: Corticosteroid use in rheumatoid arthritis: prevalence, predictors, correlates, and outcomes Journal of Rheumatology 34(4): 696-705
Furst, D.E. 1994: Predictors of worsening clinical variables and outcomes in rheumatoid arthritis Rheumatic Diseases Clinics of North America 20(2): 309-319
Dawes, P.T.; Sheeran, T.P.; Fowler, P.D.; Shadforth, M.F. 1987: Improving the response to gold or D-penicillamine by addition of sulphasalazine. a pilot study in 25 patients with rheumatoid arthritis Clinical and Experimental Rheumatology 5(2): 151-153
Vassileva, C.M.; Kwedar, K.; Boley, T.; Markwell, S.; Hazelrigg, S. 2013: Mitral valve procedure selection and outcomes in patients with rheumatoid arthritis Journal of Heart Valve Disease 22(1): 14-19
Olsen, B. 1990: Mammon's realm or Pluto's reign--is it commercialism or random decisions that determines the distribution of physicians? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 110(17): 2182-2183
Tsai, W-Shien.; Yang, Y-Hsu.; Wang, L-Chieh.; Chiang, B-Luen. 2006: Abrupt temperature change triggers arthralgia in patients with juvenile rheumatoid arthritis Journal of Microbiology Immunology and Infection 39(6): 465-470
Sheehan, T.Joseph.; DuBrava, S.; Fifield, J.; Reisine, S.; DeChello, L. 2004: Rate of change in functional limitations for patients with rheumatoid arthritis: effects of sex, age, and duration of illness Journal of Rheumatology 31(7): 1286-1292
Kavanaugh, A.; Han, C.; Bala, M. 2004: Functional status and radiographic joint damage are associated with health economic outcomes in patients with rheumatoid arthritis Journal of Rheumatology 31(5): 849-855
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683
Barrera, P.; Balsa, A.; Alves, H.; Westhovens, R.; Maenaut, K.; Cornélis, F.; Fritz, P.; Bardin, T.; Ceu Maia, M.; Lopes-Vaz, A.; Pascual Salcedo, D.; de la Concha, E.; Radstake, T.; van de Putte, L.B.; Migliorini, P.; Prudhomme, J.F.; Charron, D.; Spyropoulou, M.; Mendes, A.; Spaepen, M.; Martinez, M.; Stavropoulos, C. 2001: Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF) Journal of Rheumatology 28(5): 968-974
Chen, J.R.; Takahashi, M.; Suzuki, M.; Kushida, K.; Miyamoto, S.; Inoue, T. 1998: Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis Journal of Rheumatology 25(12): 2440-2444
Ward, M.M. 2004: Relative sensitivity to change of the erythrocyte sedimentation rate and serum C-reactive protein concentration in rheumatoid arthritis Journal of Rheumatology 31(5): 884-895
Scherler, M. 1978: Poncet--rheumatoid arthritis. Four cases of rheumatoid arthritis treated with tuberculostatics (author's transl1 Therapeutische Umschau. Revue Therapeutique 35(3): 201-206